Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

All Approvals and Tentative Approvals
March 1960

This report includes approvals of NDAs, BLAs, ANDAs, and approved supplements to those applications, and tentative ANDA/NDA approvals during the selected month. This report does not include BLAs/NDAs and supplements to those applications approved by CBER.

Click on the Drug Name and Application Number to see information about the drug (for example, regulatory history, labeling, reviews by FDA staff).

This report was produced on October 25, 2021.

Approval Date Drug Name Submission Active Ingredients Company Submission Classification * Submission Status
03/04/1960 KENALOG IN ORABASE
NDA #012097
ORIG-1 TRIAMCINOLONE ACETONIDE DELCOR ASSET CORP Type 3 - New Dosage Form Approval
03/04/1960 DECLOMYCIN
NDA #050262
SUPPL-11 DEMECLOCYCLINE HYDROCHLORIDE LEDERLE Efficacy Approval
03/09/1960 NAQUA
NDA #012265
ORIG-1 TRICHLORMETHIAZIDE SCHERING Type 1 - New Molecular Entity Approval
03/09/1960 NAQUIVAL
NDA #012265
ORIG-1 RESERPINE; TRICHLORMETHIAZIDE SCHERING Type 1 - New Molecular Entity Approval
03/17/1960 ACHROMYCIN
NDA #050276
SUPPL-19 PROCAINE HYDROCHLORIDE; TETRACYCLINE HYDROCHLORIDE LEDERLE Labeling Approval

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English